Relievant Medsystems developed a minimally-invasive outpatient procedure aimed at relieving chronic lower back pain. Their procedure, Intracept, focuses on vertebrogenic pain. Relievant Medsystems was founded in 2006 by Rex Peters, Samit Patel, and James Peacock and is headquartered in Minneapolis, MN.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
03/17/2023 | Series G | $50MM | $xx.xx | $361.21MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
458,513,658
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.2x
Dividend Rate
6.8%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
10/29/2020 | Series F | $69.7MM | $xx.xx | $360.34MM | Canaan Partners, Endeavour Vision, Lightstone Ventures, Morgenthaler Ventures, New Enterprise Associates, Vensana Capital | |
Price per Share
$xx.xx
Shares Outstanding
749,797,752
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Canaan Partners, Endeavour Vision, Lightstone Ventures, Morgenthaler Ventures, New Enterprise Associates, Vensana Capital
|
||||||
06/26/2018 | Series E | $59.31MM | $xx.xx | $115.23MM | Canaan Ventures, Emergent Ventures, Endeavour Vision, Morgenthaler, New Enterprise Associates, Rk Mellon | |
Price per Share
$xx.xx
Shares Outstanding
638,057,194
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Canaan Ventures, Emergent Ventures, Endeavour Vision, Morgenthaler, New Enterprise Associates, Rk Mellon
|
||||||
10/11/2016 | Series D-1 | $23.16MM | $xx.xx | $90.33MM | Canaan Partners, Emergent Medical Partners, Morgenthaler, New Enterprise Associates | |
Price per Share
$xx.xx
Shares Outstanding
90,579,887
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
2.8x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Canaan Partners, Emergent Medical Partners, Morgenthaler, New Enterprise Associates
|
||||||
03/28/2012 | Series D | $25.77MM | $xx.xx | $64.66MM | Canaan Partners, Emergent Medical Partners, Morgenthaler, New Enterprise Associates, Onset Ventures | |
Price per Share
$xx.xx
Shares Outstanding
100,808,708
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.5x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Canaan Partners, Emergent Medical Partners, Morgenthaler, New Enterprise Associates, Onset Ventures
|
||||||
07/07/2009 | Series C | $15.17MM | $xx.xx | $42.55MM | Canaan Partners, Emergent Medical Partners, Morgenthaler, Onset Ventures | |
Price per Share
$xx.xx
Shares Outstanding
30,348,556
Liquidation Pref Order
5
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
2.3x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Canaan Partners, Emergent Medical Partners, Morgenthaler, Onset Ventures
|
||||||
10/22/2006 | Series B-1 | $2.03MM | $xx.xx | $15.52MM | Bcm Technologies, Canaan Partners, Onset Ventures | |
Price per Share
$xx.xx
Shares Outstanding
2,976,497
Liquidation Pref Order
5
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
3.1x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Bcm Technologies, Canaan Partners, Onset Ventures
|
||||||
10/22/2006 | Series B | $2.51MM | $xx.xx | $15.52MM | Bcm Technologies, Canaan Partners, Onset Ventures | |
Price per Share
$xx.xx
Shares Outstanding
4,972,228
Liquidation Pref Order
5
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
2.3x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Bcm Technologies, Canaan Partners, Onset Ventures
|